These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 23166755)
1. Activated human T cells secrete exosomes that participate in IL-2 mediated immune response signaling. Wahlgren J; Karlson Tde L; Glader P; Telemo E; Valadi H PLoS One; 2012; 7(11):e49723. PubMed ID: 23166755 [TBL] [Abstract][Full Text] [Related]
2. Activation of peripheral CD8+ T lymphocytes via CD28 plus CD2: evidence for IL-2 gene transcription mediated by CD28 activation. Carabasi MH; DiSanto JP; Yang SY; Dupont B Tissue Antigens; 1991 Jan; 37(1):26-32. PubMed ID: 1676547 [TBL] [Abstract][Full Text] [Related]
3. Molecular pathway profiling of T lymphocyte signal transduction pathways; Th1 and Th2 genomic fingerprints are defined by TCR and CD28-mediated signaling. Smeets RL; Fleuren WW; He X; Vink PM; Wijnands F; Gorecka M; Klop H; Bauerschmidt S; Garritsen A; Koenen HJ; Joosten I; Boots AM; Alkema W BMC Immunol; 2012 Mar; 13():12. PubMed ID: 22413885 [TBL] [Abstract][Full Text] [Related]
4. Exosomes released from Mycoplasma infected tumor cells activate inhibitory B cells. Yang C; Chalasani G; Ng YH; Robbins PD PLoS One; 2012; 7(4):e36138. PubMed ID: 22558358 [TBL] [Abstract][Full Text] [Related]
5. Ex vivo expansion of human CD8+ T cells using autologous CD4+ T cell help. Butler MO; Imataki O; Yamashita Y; Tanaka M; Ansén S; Berezovskaya A; Metzler G; Milstein MI; Mooney MM; Murray AP; Mano H; Nadler LM; Hirano N PLoS One; 2012; 7(1):e30229. PubMed ID: 22279573 [TBL] [Abstract][Full Text] [Related]
6. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule. Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771 [TBL] [Abstract][Full Text] [Related]
7. IL-12 stimulates CTLs to secrete exosomes capable of activating bystander CD8 Li L; Jay SM; Wang Y; Wu SW; Xiao Z Sci Rep; 2017 Oct; 7(1):13365. PubMed ID: 29042682 [TBL] [Abstract][Full Text] [Related]
8. [Interleukin-12 restores and promotes the T-cell immune function inhibited by 5-fluorouracil]. Chi PD; Li L; Fan YY; Wu CY Ai Zheng; 2007 Aug; 26(8):801-8. PubMed ID: 17697537 [TBL] [Abstract][Full Text] [Related]
9. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function. Filaci G; Fravega M; Negrini S; Procopio F; Fenoglio D; Rizzi M; Brenci S; Contini P; Olive D; Ghio M; Setti M; Accolla RS; Puppo F; Indiveri F Hum Immunol; 2004 Feb; 65(2):142-56. PubMed ID: 14969769 [TBL] [Abstract][Full Text] [Related]
10. Effects of Korean mistletoe lectin (Viscum album coloratum) on proliferation and cytokine expression in human peripheral blood mononuclear cells and T-lymphocytes. Lyu SY; Park WB Arch Pharm Res; 2007 Oct; 30(10):1252-64. PubMed ID: 18038904 [TBL] [Abstract][Full Text] [Related]
11. The regulation of phenotype and function of human liver CD3+/CD56+ lymphocytes, and cells that also co-express CD8 by IL-2, IL-12 and anti-CD3 monoclonal antibody. Jin Y; Fuller L; Carreno M; Esquenazi V; Tzakis AG; Miller J Hum Immunol; 1998 Jun; 59(6):352-62. PubMed ID: 9634197 [TBL] [Abstract][Full Text] [Related]
12. Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Clayton A; Mitchell JP; Court J; Mason MD; Tabi Z Cancer Res; 2007 Aug; 67(15):7458-66. PubMed ID: 17671216 [TBL] [Abstract][Full Text] [Related]
13. Increased interleukin-10 production by ASC-deficient CD4+ T cells impairs bystander T-cell proliferation. Narayan S; Kolly L; So A; Busso N Immunology; 2011 Sep; 134(1):33-40. PubMed ID: 21718313 [TBL] [Abstract][Full Text] [Related]
14. CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma. Pohl C; Denfeld R; Renner C; Jung W; Bohlen H; Sahin U; Hombach A; van Lier R; Schwonzen M; Diehl V Int J Cancer; 1993 Jul; 54(5):820-7. PubMed ID: 7686889 [TBL] [Abstract][Full Text] [Related]
15. Evidence for the involvement of three distinct signals in the induction of IL-2 gene expression in human T lymphocytes. June CH; Ledbetter JA; Lindsten T; Thompson CB J Immunol; 1989 Jul; 143(1):153-61. PubMed ID: 2543699 [TBL] [Abstract][Full Text] [Related]
16. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2. Gargett T; Brown MP Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of anti-CD3 monoclonal antibody-induced T-cell proliferation and interleukin-2 secretion by physiologic combinations of dexamethasone and prostaglandin E2. Elliott L; Brooks W; Roszman T Cell Mol Neurobiol; 1993 Dec; 13(6):579-92. PubMed ID: 7910781 [TBL] [Abstract][Full Text] [Related]
18. Effect of interleukin-15 on effector and regulatory function of anti-CD3/anti-CD28-stimulated CD4(+) T cells. Lin SJ; Cheng PJ; Hsiao SS Bone Marrow Transplant; 2006 May; 37(9):881-7. PubMed ID: 16565741 [TBL] [Abstract][Full Text] [Related]
19. Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal. Tamang DL; Redelman D; Alves BN; Vollger L; Bethley C; Hudig D Cytokine; 2006 Nov; 36(3-4):148-59. PubMed ID: 17188506 [TBL] [Abstract][Full Text] [Related]
20. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. Turka LA; Ledbetter JA; Lee K; June CH; Thompson CB J Immunol; 1990 Mar; 144(5):1646-53. PubMed ID: 2155264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]